HarmonyFidelisHarmonyFidelis
Login
NewsMajor ProjectsActorsAcademy
Back to actors

Calico

Calico Life Sciences (Alphabet)

Corporation

About

Laboratoire de recherche du vieillissement. Drug discovery, biomarkers, cellular reprogramming, aging biology.

Headquarters

San Francisco, California, USA

Founded

2013

Type

Corporation

Ecosystems

1

Mission

“Harness advanced technologies to increase human healthspan.”

Focus areas

Aging biologyDrug discoverySenolyticsCellular reprogrammingBiomarkers

Ecosystem participation

Longevity & Anti-Aging

Extending healthy life: aging biology, cell therapies, regeneration

View ecosystem →

Strategic roadmap

2025 Q3

First senolytic drug Phase 2 completion

◯ Planned

Safety and efficacy data in human aging markers.

Longevity & Anti-Aging
2026 Q4

Combination therapy trials initiate

◯ Planned

Multiple senolytic agents + reprogramming regimen.

Longevity & Anti-Aging
2028 Q2

Age reversal demonstrated 5+ years

◯ Planned

Biomarker validation. Aging reversal in humans.

Longevity & Anti-Aging

External resources

Official website

https://www.calicolabs.com

Research

https://www.calicolabs.com/research

Pipeline

https://www.calicolabs.com/